Evidence map›Paper›PMID 34034827›Full record

ArticleInfectious diseases of poverty2021

Prevalence of Plasmodium falciparum isolates lacking the histidine rich protein 2 gene among symptomatic malaria patients in Kwilu Province of the Democratic Republic of Congo.

Yannick Bazitama Munyeku, Alain Abera Musaka, Medard Ernest, Chris Smith, Paul Mankadi Mansiangi, Richard Culleton

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases of poverty, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. IJID regions · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 4 countries.

Yannick Bazitama MunyekuDirection Des Laboratoires de Santé, Ministère de La Santé, Kinshasa, Democratic Republic of the Congo. ymunyeku@gmail.com.
Alain Abera MusakaDivision Provinciale de La Santé du Kwilu, Kwilu, Democratic Republic of the Congo.
Medard ErnestMalaria Unit, Department of Pathology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Chris SmithGraduate School of Tropical Medicine and Global Health (TMGH), Nagasaki University, Nagasaki, Japan.
Paul Mankadi MansiangiKinshasa School of Public Health, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Richard CulletonGraduate School of Tropical Medicine and Global Health (TMGH), Nagasaki University, Nagasaki, Japan. culleton.richard.oe@ehime-u.ac.jp.ORCID http://orcid.org/0000-0001-8808-5771
Ehime University · JPInstitut Supérieur de Technique Médicale · CDLondon School of Hygiene & Tropical Medicine · GBMinistry of Public Health · CDNational Institutes of Health · USUniversity of Kinshasa · CD

Funding

Japan Society for the Promotion of Science 16K21233 and 19K07526
6 · The paper itself

Abstract

backgroundMalaria rapid diagnostic tests have become a primary and critical tool for malaria diagnosis in malaria-endemic countries where Plasmodium falciparum Histidine Rich Protein 2-based rapid diagnostic tests (PfHRP2-based RDTs) are widely used. However, in the last decade, the accuracy of PfHRP2-based RDTs has been challenged by the emergence of P. falciparum strains harbouring deletions of the P. falciparum histidine rich protein 2 (pfhrp2) gene, resulting in false-negative results. In the Democratic Republic of Congo (D.R. Congo), little is known about the prevalence of the pfhrp2 gene deletion among P. falciparum isolates infecting symptomatic patients, especially in low to moderate transmission areas where pfhrp2 deletion parasites are assumed to emerge and spread. Here we determine the local prevalence and factors associated with pfhrp2 gene deletions among symptomatic malaria patients in the Kwilu Province of the D.R. Congo.

methodsWe used secondary data from a prospective health facility-based cross-sectional study conducted in 2018. Blood was collected for microscopy, PfHRP2-RDT, and spotted onto Whatman filter paper for downstream genetic analysis. Genomic DNA was extracted and used to perform PCR assays for the detection and confirmation of pfhrp2 gene deletions. Fischer's exact and the Kruskal-Wallis tests were applied to look for associations between potential explanatory variables and the pfhrp2 gene deletion with a level of statistical significance set at P < 0.05.

resultsOf the 684 enrolled symptomatic patients, 391 (57.7%) were female. The majority (87.7%) reported the presence of mosquito breeding sites within the household's compound, and fever was the most reported symptom (81.6%). The overall prevalence of the pfhrp2 gene deletion was 9.2% (95% CI: 6.7%-12.1%). The deletion of the pfhrp2 gene was associated with health zone of origin (P = 0.012) and age (P = 0.019). Among false-negative PfHRP2-RDT results, only 9.9% were due to pfhrp2 gene deletion.

conclusionsP. falciparum isolates with pfhrp2 gene deletions are relatively common among symptomatic patients in Kwilu province. Further investigations are needed to provide enough evidence for policy change. Meanwhile, the use of RDTs targeting PfHRP2 and parasite lactate dehydrogenase (pLDH) antigens could limit the spread of deleted isolates.

Indexed as

MalariaMalaria, FalciparumAnimalsAntigens, ProtozoanCross-Sectional StudiesDemocratic Republic of the CongoDiagnostic Tests, RoutineFemaleHistidineHumansPlasmodium falciparumPrevalenceProspective StudiesAntigens, ProtozoanHistidineFalse negativeGene deletionPlasmodium falciparum histidine rich protein 2Rapid diagnostic testSymptomatic patient

Identifiers

PMID34034827
PMCPMC8146217
OpenAlexW3165469172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.